ArticlePLOS global public health2026
Māori and Pacific People's perspectives on Group A Streptococcus vaccine development and delivery in Aotearoa, New Zealand.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aotearoa New Zealand experiences a disproportionately high incidence of Group A Streptococcus (Strep A) disease, particularly acute rheumatic fever (ARF), with Pacific children 80 times and Indigenous Māori children 36 times more likely to develop ARF than children of other ethnicities. This qualitative study explored Māori and Pacific Peoples' perspectives on Strep A vaccine development. Guided by Kaupapa Māori and Pacific-centred research approaches, semi-structured interviews were conducted with 29 participants, including 20 whānau (family) members and nine healthcare stakeholders. Interviews were recorded, transcribed verbatim, and analysed using a general inductive thematic approach. Three interconnected themes emerged: Perceptions of ARF, vaccine development, and vaccine delivery. These themes were grounded in cultural values such as hauora (wellbeing), whanaungatanga (relationships), kotahitanga (collective action), and tino rangatiratanga (sovereignty and self-determination). Participants' perspectives were shaped by lived experiences of colonisation and the recent Covid-19 vaccine rollout. Māori and Pacific-led approaches rooted in cultural knowledge systems were consistently highlighted. Participants emphasised that the current healthcare system is not fit-for-purpose for Māori and Pacific health and wellbeing and must be realigned to better reflect varying worldviews. Vaccine delivery models must be holistic and flexible, incorporating a whānau ora (family-centred) approach. While recognising the importance of a Strep A vaccine, participants stressed that addressing social determinants of health, such as housing, poverty, and access to health care is essential to reducing disease burden. These findings demonstrate that culturally responsive approaches are essential for successful vaccination programmes. In Aotearoa New Zealand, this requires embedding Māori and Pacific leadership, perspectives and participation from design to delivery, together with strengthened Māori and Pacific health workforces.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.